Biblio

Export 130 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is tau Proteins  [Clear All Filters]
2024
R. Ali Syed, Hayat, M., Qaiser, H., Uzair, M., Al-Regaiey, K., Khallaf, R., Kaleem, I., and Bashir, S., Aging-Related Protein Alterations in the Brain., J Alzheimers Dis, vol. 99, no. s1, pp. S5-S22, 2024.
S. J. Czuczwar, Kocki, J., Miziak, B., Bogucki, J., Bogucka-Kocka, A., and Pluta, R., Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years., J Alzheimers Dis, vol. 98, no. 1, pp. 151-161, 2024.
I. Ferrer, Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging., J Alzheimers Dis, vol. 100, no. s1, pp. S153-S164, 2024.
R. W. B. Love, Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer's Disease., J Alzheimers Dis, vol. 98, no. 4, pp. 1235-1241, 2024.
Z. Li, Fan, Z., and Zhang, Q., The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis., J Alzheimers Dis, vol. 98, no. 1, pp. 13-32, 2024.
I. J. Sible and Nation, D. A., Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial., J Alzheimers Dis, vol. 97, no. 4, pp. 1851-1860, 2024.
A. Mahzarnia, Lutz, M. W., and Badea, A., A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5., J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
I. Frentz, van Arendonk, J., Leeuwis, A. E., Vernooij, M. W., van der Flier, W. M., Bos, D., De Deyn, P. Paul, Wolters, F. J., and M Ikram, A., Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function., J Alzheimers Dis, vol. 97, no. 2, pp. 953-961, 2024.
K. Ishii, Yamada, T., Hanaoka, K., Kaida, H., Kojita, Y., Kono, A., Hanada, K., Saigoh, K., Sakuta, S., Hashimoto, M., Kato, T., and Nakamura, A., Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain., J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
P. Y. Ng, Zhang, C., Li, H., and Baker, D. J., Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice., J Alzheimers Dis, vol. 97, no. 4, pp. 1751-1763, 2024.
D. Gohel, Zhang, P., Gupta, A. Kumar, Li, Y., Chiang, C. - W., Li, L., Hou, Y., Pieper, A. A., Cummings, J., and Cheng, F., Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons., J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.
E. M. Sigurdsson, Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies., J Alzheimers Dis, vol. 101, no. s1, pp. S129-S140, 2024.
J. Rodrigo Do Santos, Catalão, C. Henrique R., Vulczak, A., Azzolini, A. Elisa Cale, and Alberici, L. Carla, Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease., J Alzheimers Dis, vol. 102, no. 2, pp. 424-436, 2024.
2023
C. Grobler, van Tongeren, M., Gettemans, J., Kell, D. B., and Pretorius, E., Alzheimer's Disease: A Systems View Provides a Unifying Explanation of Its Development., J Alzheimers Dis, vol. 91, no. 1, pp. 43-70, 2023.
C. Gonzalez, Mimmack, K. J., Amariglio, R. E., J Becker, A., Chhatwal, J. P., Fitzpatrick, C. D., Gatchel, J. R., Johnson, K. A., Katz, Z. S., Kuppe, M. K., Locascio, J. J., Udeogu, O. J., Papp, K. V., Premnath, P., Properzi, M. J., Rentz, D. M., Schultz, A. P., Sperling, R. A., Vannini, P., Wang, S., and Marshall, G. A., Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings., J Alzheimers Dis, vol. 94, no. 1, pp. 217-226, 2023.
C. Giuseppina Bonomi, Assogna, M., Di Donna, M. Gaia, Bernocchi, F., De Lucia, V., Nuccetelli, M., Fiorelli, D., Loizzo, S., Mercuri, N. Biagio, Koch, G., Martorana, A., and Motta, C., Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum., J Alzheimers Dis, vol. 92, no. 4, pp. 1385-1397, 2023.
K. Rajah Kumaran, Yunusa, S., Perimal, E., Wahab, H., Müller, C. P., and Hassan, Z., Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective., J Alzheimers Dis, vol. 91, no. 2, pp. 507-530, 2023.
A. L. Wiseman, Briggs, C. A., Peritt, A., Kapecki, N., Peterson, D. A., Shim, S. S., and Stutzmann, G. E., Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 91, no. 1, pp. 273-290, 2023.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.

Pages